» Articles » PMID: 30501125

Toward Exosome-Based Neuronal Diagnostic Devices

Overview
Publisher MDPI
Date 2018 Dec 2
PMID 30501125
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Targeting exosome for liquid biopsy has gained significant attention for its diagnostic and therapeutic potential. For detecting neuronal disease diagnosis such as Alzheimer's disease (AD), the main technique for identifying AD still relies on positron-emission tomography (PET) imaging to detect the presence of amyloid-β (Aβ). While the detection of Aβ in cerebrospinal fluid has also been suggested as a marker for AD, the lack of quantitative measurements has compromised existing assays. In cerebrospinal fluid, in addition to Aβ, T-Tau, and P-Tau, alpha-synuclein has been considered a biomarker of neurodegeneration. This review suggests that and explains how the exosome can be used as a neuronal diagnostic component. To this end, we summarize current progress in exosome preparation/isolation and quantification techniques and comment on the outlooks for neuronal exosome-based diagnostic techniques.

Citing Articles

Proteomics analysis of extracellular vesicles for biomarkers of autism spectrum disorder.

Moussa H, Shin K, de la Fuente A, Bensmail I, Abdesselem H, Ponraj J Front Mol Biosci. 2024; 11:1467398.

PMID: 39606031 PMC: 11599737. DOI: 10.3389/fmolb.2024.1467398.


Differentiation of Human Adipose-derived Stem Cells to Exosome-affected Neural-like Cells Extracted from Human Cerebrospinal Fluid Using Bioprinting Process.

Cheravi M, Baharara J, Yaghmaei P, Roudbari N Curr Stem Cell Res Ther. 2023; 19(7):1042-1054.

PMID: 37957915 DOI: 10.2174/011574888X270145231102062259.


The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring.

Batool S, Yekula A, Khanna P, Hsia T, Gamblin A, Ekanayake E Cell Rep Med. 2023; 4(10):101198.

PMID: 37716353 PMC: 10591039. DOI: 10.1016/j.xcrm.2023.101198.


Exosomes as Novel Delivery Systems for Application in Traditional Chinese Medicine.

Chen Q, Wu D, Wang Y, Chen Z Molecules. 2022; 27(22).

PMID: 36431890 PMC: 9695524. DOI: 10.3390/molecules27227789.


Is liquid biopsy mature enough for the diagnosis of Alzheimer's disease?.

Gong X, Zhang H, Liu X, Liu Y, Liu J, Fapohunda F Front Aging Neurosci. 2022; 14:977999.

PMID: 35992602 PMC: 9389010. DOI: 10.3389/fnagi.2022.977999.


References
1.
Mattson M, Pedersen W, Duan W, Culmsee C, Camandola S . Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases. Ann N Y Acad Sci. 2000; 893:154-75. DOI: 10.1111/j.1749-6632.1999.tb07824.x. View

2.
Clayton A, COURT J, Navabi H, Adams M, Mason M, Hobot J . Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods. 2001; 247(1-2):163-74. DOI: 10.1016/s0022-1759(00)00321-5. View

3.
Terwel D, Dewachter I, Van Leuven F . Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease. Neuromolecular Med. 2002; 2(2):151-65. DOI: 10.1385/NMM:2:2:151. View

4.
Mason S, La S, Mytych D, Swanson S, Ferbas J . Validation of the BIACORE 3000 platform for detection of antibodies against erythropoietic agents in human serum samples. Curr Med Res Opin. 2003; 19(7):651-9. DOI: 10.1185/030079903125002414. View

5.
Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B . Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem. 2004; 51(2):336-45. DOI: 10.1373/clinchem.2004.039347. View